Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,877 | 150 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $347.47 | 19 | $0 (2024) |
| Lilly USA, LLC | $307.70 | 18 | $0 (2024) |
| GlaxoSmithKline, LLC. | $296.98 | 18 | $0 (2024) |
| Novo Nordisk Inc | $289.36 | 16 | $0 (2024) |
| Abbott Laboratories | $234.86 | 14 | $0 (2024) |
| PFIZER INC. | $166.57 | 10 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $125.00 | 1 | $0 (2019) |
| Sumitomo Pharma America, Inc. | $112.40 | 4 | $0 (2024) |
| SHIELD THERAPEUTICS INC | $103.32 | 5 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $101.79 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,190 | 62 | ABBVIE INC. ($177.48) |
| 2023 | $1,169 | 64 | Abbott Laboratories ($153.42) |
| 2022 | $261.54 | 15 | PFIZER INC. ($47.11) |
| 2020 | $26.01 | 2 | Janssen Pharmaceuticals, Inc ($14.94) |
| 2019 | $149.76 | 2 | Actelion Pharmaceuticals US, Inc. ($125.00) |
| 2018 | $80.62 | 5 | GlaxoSmithKline, LLC. ($48.54) |
All Payment Transactions
150 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/28/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: VACCINES | ||||||
| 09/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: RESPIRATORY | ||||||
| 09/23/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $8.87 | General |
| Category: Diabetes | ||||||
| 09/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.54 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 09/17/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $33.69 | General |
| Category: Endocrinology | ||||||
| 09/04/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: Diabetes | ||||||
| 09/03/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: Biological | ||||||
| 08/29/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $2.55 | General |
| Category: Diabetes | ||||||
| 08/27/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: PAIN | ||||||
| 08/13/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $73.13 | General |
| Category: UROLOGY | ||||||
| 08/06/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Diabetes | ||||||
| 08/06/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Diabetes Care | ||||||
| 07/25/2024 | SCILEX PHARMACEUTICALS INC. | ELYXYB - CELECOXIB (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Pain Management | ||||||
| 07/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: NEUROSCIENCE | ||||||
| 07/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $29.98 | General |
| Category: RESPIRATORY | ||||||
| 07/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: RESPIRATORY | ||||||
| 07/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Diabetes | ||||||
| 07/08/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/02/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: Diabetes | ||||||
| 06/27/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: Obesity | ||||||
| 06/18/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: NEUROSCIENCE | ||||||
| 06/13/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: Diabetes | ||||||
| 06/11/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: Biological | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 35 | 2,144 | 3,424 | $278,843 | $103,286 |
| 2022 | 33 | 1,917 | 3,200 | $243,434 | $95,191 |
| 2021 | 34 | 1,823 | 4,112 | $242,145 | $98,293 |
| 2020 | 35 | 1,617 | 3,565 | $227,776 | $75,754 |
All Medicare Procedures & Services
137 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 413 | 682 | $107,420 | $50,828 | 47.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 113 | 139 | $14,975 | $7,757 | 51.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 79 | 80 | $7,950 | $5,604 | 70.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 34 | 34 | $5,610 | $4,163 | 74.2% |
| 77067 | Screening mammography | Office | 2023 | 53 | 53 | $16,960 | $4,038 | 23.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 17 | 17 | $11,220 | $3,542 | 31.6% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 18 | 18 | $8,460 | $2,659 | 31.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 16 | 16 | $4,720 | $2,516 | 53.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 81 | 82 | $3,280 | $2,367 | 72.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 211 | 268 | $4,020 | $2,201 | 54.8% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 109 | 123 | $8,610 | $1,996 | 23.2% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 14 | 14 | $19,600 | $1,982 | 10.1% |
| 82306 | Vitamin d-3 level | Office | 2023 | 61 | 64 | $7,040 | $1,828 | 26.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 146 | 161 | $9,660 | $1,638 | 17.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 116 | 120 | $8,400 | $1,539 | 18.3% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 23 | 23 | $3,680 | $1,156 | 31.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 87 | 115 | $5,175 | $1,085 | 21.0% |
| 71271 | Low dose ct scan of chest for lung cancer screening | Office | 2023 | 13 | 13 | $5,395 | $1,060 | 19.6% |
| 77063 | Screening 3d breast mammography | Office | 2023 | 53 | 53 | $3,710 | $1,049 | 28.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 88 | 89 | $3,560 | $662.07 | 18.6% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 13 | 13 | $1,625 | $470.04 | 28.9% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 27 | 27 | $2,160 | $433.68 | 20.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 25 | 25 | $1,000 | $410.88 | 41.1% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 23 | 23 | $1,495 | $325.16 | 21.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 25 | 40 | $2,070 | $296.03 | 14.3% |
About Dr. Donna Gregory, MD
Dr. Donna Gregory, MD is a Family Medicine healthcare provider based in Cartersville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013987650.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Donna Gregory, MD has received a total of $2,877 in payments from pharmaceutical and medical device companies, with $1,190 received in 2024. These payments were reported across 150 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($2,877).
As a Medicare-enrolled provider, Gregory has provided services to 7,501 Medicare beneficiaries, totaling 14,301 services with total Medicare billing of $372,524. Data is available for 4 years (2020–2023), covering 137 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Cartersville, GA
- Active Since 01/25/2006
- Last Updated 04/24/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1013987650
Products in Payments
- VRAYLAR (Drug) $211.65
- MOUNJARO (Drug) $185.19
- TRELEGY ELLIPTA (Drug) $161.42
- Ozempic (Drug) $125.35
- Rybelsus (Drug) $115.04
- GEMTESA (Drug) $112.40
- ACCRUFER (Drug) $103.32
- Kerendia (Drug) $101.79
- Dexcom G6 Transmitter (Medical Supply) $96.06
- AREXVY (Drug) $95.27
- UBRELVY (Drug) $82.74
- PREVNAR 20 (Biological) $73.14
- Veozah (Drug) $70.89
- NURTEC ODT (Drug) $66.96
- FREESTYLE LIBRE 3 (Device) $59.36
- OFEV (Drug) $57.80
- JARDIANCE (Drug) $56.27
- DRAGONFLY OPSTAR (Device) $55.74
- QULIPTA (Drug) $53.08
- ELIQUIS (Drug) $50.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Cartersville
Louis Spencer, M.d, M.D
Family Medicine — Payments: $12,393
Dr. Carl Bevill, Md, MD
Family Medicine — Payments: $12,235
Mary Barfield, Md, MD
Family Medicine — Payments: $7,612
Mr. Lee Battle, Md, MD
Family Medicine — Payments: $6,097
Dr. James Williams, Md, MD
Family Medicine — Payments: $5,932
Dr. Richard Britton, D.o, D.O
Family Medicine — Payments: $5,359